TAHP Medical + Pharmacy Directors Forum – March 2023
These invitation-only events offer our health plan Medical and Pharmacy Directors the unique opportunity to interface with their peers and hear from state and national experts as they discuss common challenges and best practices.
Austin, TX 78701
Hampton Inn, San Jacinto Room, 200 San Jacinto Blvd
Mar 28, 2023
9:00 am - 4:00 pm
Sarepta Gene Transfer Therapy for Duchenne Muscular Dystrophy
This presentation will provide an introduction and clinical data review of the novel and innovative Sarepta Gene Transfer therapy for Duchenne Muscular Dystrophy (Delandistrogene moxeparvovec/SRP-9001).
Speaker: Kathrin Kucharski, PharmD, Sarepta
Telemedicine to Advance Population Health & Equity in Maternity Care
The U.S. has some of the highest rates of preterm birth, NICU admissions, and cesarean deliveries caused by gaps in our current prenatal and newborn care model. In Texas, cesarean delivery rates are higher than the national average, and fewer women receive first trimester care compared to other states. These outcomes indicate the opportunity for better population health management to improve maternal health, a key focus area for the Texas Department of State Health Services and organizations across the state. In this session, we’ll discuss clinical strategies using virtual care to build an effective, sustainable maternal-newborn population health program.
Speaker: Isabelle Von Kohorn, MD, PhD, Pomelo Care
Trodelvy and Sunlenca Medical value Presentation
This presentation will provide background, guidelines, MOA, and Phase 3 Clinical Trial that led to the approval of the above products.
Speaker: Porscha Showers, PharmD RpH AAHIVE, Gilead Sciences
Lunch - Legislative Update
TAHP will provide lunch on-site and TAHP staff will give a brief update on the current legislative session.
BioSpecialized™ Devoted to life-changing treatments
Biosimilars put biologic medicines within reach for more patients. With demonstrated biosimilarity to the reference products at lower costs to patients and providers, biosimilars play an important role in the future of health care by improving access to medications and encouraging investments in research and innovation.
Speakers: Nazanin Ashourian, PhD, Sr. Director, Medical Affairs and Brandee Pappalardo, PhD, MPH, Sr. VP, Chief Medical Officer, Fresenius Kabi USA
HHSC Agency Update
Dr. Glenn will provide an update from HHSC Medicaid/CHIP Services Office of the Medical Director.
Speaker: Dr. Lisa B. Glenn, Senior Associate Medical Director, HHSC
Solutions aimed at addressing gaps in care for underserved populations
Access to and care compliance are a growing concern. Preterm births, which continue to rise, is highlighted. This presentation will outline key efforts to improve access, care compliance, health literacy, and healthy behaviors for improved pregnancy outcomes.
Speakers: Michael Lemnitzer, State Government Healthcare, Phillips
Raymon uit de Bulten, Pregnancy+ Health Insurance and Payers, Phillips
Steven Nelson, Personal Health business
Child First and Nurse Family Partnership Models of Care: Improving Child and Maternal Health
Learn about a new model of care called Child First that is being implemented in many states and considered by the Texas Legislature this session. Child First is a national, evidence-based, two-generation model that works with very challenged young children and families, providing intensive, mental-health, home-visiting services. Nurse Family Partnership (NFP) staff will also provide an update on NFP – new opportunities, what is happening at the Legislature, and discuss APM ideas.
Speaker: Brittany Dawn McAllister, MPH, Senior Government Affairs Manager, The National Service Office for Nurse-Family Partnership and Child First
Kathrin Kucharski, PharmD
Sr. Director, Medical Managed Care, Sarepta
Kathrin brings over 30 years of health care experience that spans 20 years in the pharmaceutical industry and 15 years in the health care delivery system.
She currently holds the position of Senior Director, Medical Managed Care at Sarepta Therapeutics, a precision genetics medicine company. In this role, she provides field medical support and communicates scientific information focused in Duchenne Muscular Dystrophy, other dystrophinopathy therapeutic areas and Sarepta pipeline products to payer and managed care organizations.
Her professional background includes multiple industry medical affairs and health system roles and encompasses expertise in several therapeutic areas including the evolving field of gene therapy. She has diverse channel experience including health care systems, payers, PBM’s, ACO’s, and IDN’s.×
Isabelle Von Kohorn, MD, PhD
VP, Medical Affairs, Pomelo Care
Dr. Isabelle Von Kohorn, is the Vice President, Medical Affairs of Pomelo Care, a virtual medical practice founded to address underlying risk factors to improve maternal and newborn health. Prior to Pomelo, she was Chief of Neonatology at Holy Cross Hospital in Silver Spring, Maryland, one of the largest birth hospitals in the country. She previously served as a program officer with the National Academy of Medicine’s Leadership Consortium for Value & Science-Driven Health Care. Dr. Von Kohorn received her undergraduate degree from the School of Public and International Affairs at Princeton University and her M.D. from the University of Pennsylvania. She completed her residency and chief residency in Pediatrics at UCSF, where she received the UCSF Medical Center Exceptional Physician Award. She completed her fellowship in Neonatal-Perinatal Medicine at Yale University, where she also received her Ph.D. in Investigative Medicine. She enjoys traveling and watching spy movies with her family.
Porscha Showers, PharmD RpH AAHIVE
Patient Access and Quality Principal Medical Scientist, Gilead Sciences
Dr. Porscha Showers lives in Dallas Fort Worth Area, but grew up in the greater New Orleans area. Her current role is a Patient Access and Quality Principal Medical Scientist at Gilead Sciences where she talks to value based decision makers regarding the value of Gilead’s portfolio which includes, Oncology, HIV, COVID-19, Hepatitis C and B/D.
Dr. Showers’ prior experiences include the following: Oncology Clinical Trials Pharmacist, Clinical Pharmacist at various hospitals and Staff Pharmacist at Walgreens. She was at Aetna where she served in numerous roles with her most recent being Formulary Manager for 4 Medicaid Plans and 5 Duals Plans while also serving as Assistant Pharmacy Director for Arizona Medicare. Before joining Gilead in 2019, Dr. Showers was an Evidence and Outcomes Liaison at Eli Lilly and Company for the Central Region.
Dr. Showers received her PharmD in 2014 from the Xavier University of Louisiana in New Orleans, Louisiana. She is an active member of the North Dallas Alumnae Chapter of Delta Sigma Theta Sorority, Inc., DFW Graduate Chapter of Kappa Psi Pharmaceutical Fraternity, Inc. and DFW Xavier University of Louisiana Alumni Chapter. She also served on the Board of Directors for the Minority Women’s Pharmacist Association. In her spare time, she loves solo traveling to various countries around the world, exercising and Do It Yourself Projects.×
Sr. Director, Medical Affairs, Fresenius Kabi
Nazanin Ashourian is the head of U.S. Biosimilars Medical Affairs for Fresenius Kabi. In her role, Nazanin leads all Medical Affairs activities related to the biosimilars portfolio. Prior to joining Fresenius Kabi, Nazanin spent six years at AbbVie (previously Allergan) with roles of increasing responsibility supporting biologics, small molecules, and medical devices. Nazanin holds a Bachelor of Science in molecular and cellular biology from the University of Illinois at Urbana-Champaign and a PhD in biochemistry and molecular genetics from the Johns Hopkins University.×
Brandee Pappalardo, PhD, MPH
Sr. Vice President, Chief Medical Officer, Fresenius Kabi
Brandee Pappalardo joined Fresenius Kabi in April 2022 as Senior Vice President, Chief Medical Officer, North America. In her current role, Brandee oversees all Vigilance and Medical Affairs activities related to Pharma Generics/Simplist, Parenteral Nutrition, Biosimilars, Human Factors and Infusion Devices. Prior to joining Fresenius Kabi, she spent 17 years at AbbVie holding affiliate, area and global medical roles of increasing responsibility; her last role as Vice President, Immunology, US Medical Affairs. Brandee holds a bachelor’s degree in Biology from Duke University, an MPH in Epidemiology from UC Berkeley, and a PhD in immunology from NC State University.×
Lisa Glenn, MD
Senior Associate Medical Director for Medicaid-CHIP, HHSC
Dr. Glenn is a graduate of Texas A&M University and UT Southwestern Medical School. She has work experience in the private sector in solo private practice as well as 16 years in the Community Health Centers in Austin with increasing administrative responsibilities finishing her tenure there as Senior Medical Director. Prior to joining the Department of Aging and Disability Services as the State Office Physician in January of 2012, she was the Medical Director of Central Health, the Travis County Healthcare District. In 2016, Dr. Glenn transitioned into HHSC as the Senior Associate Medical Director for Medicaid-CHIP. She holds board certifications from the American Board of Family Medicine since 1990 and the American Board of Quality Assurance and Utilization Review Physicians since 2007. She is a member of the Texas Medical Association, Travis County Medical Society, American Academy of Family Physicians and Texas Academy of Family Physicians.×
State Government Healthcare, Phillips
Michael Lemnitzer leads the State Government Healthcare business focused on introducing state and local governments with technology across the Philips portfolio such as ventilators, maternal health solutions, remote patient monitoring, eICU/tele-critical care, rural cancer screening, and interoperable HIE Image Network solutions. Mike also serves on the Board of Directors for Texas e-Health Alliance.×
Raymon uit de Bulten
Pregnancy + Health Insurance and Payers, Phillips
Raymon uit de Bulten leads the Pregnancy + Health Insurance and Payers business. Raymon is assisting governments and health plans to improve maternal and infant health while reducing the cost of care. He is focused on introducing solutions that provide a comprehensive pregnancy journey that helps women start with prenatal care on time and increases care compliance.×
Personal Health Business, Phillips
Steven Nelson leads the Personal Health business focusing on solutions in the oral health and maternal health spaces. Working with Payer partners, the aim is to improve better health outcomes patient and staff experience, and lower cost of care. These solutions support chronic condition management, behavioral changes, and access to care.×
Brittany Dawn McAllister, MPH
Senior Government Affairs Manager, The National Service Office for Nurse-Family Partnership and Child First
Brittany Dawn McAllister serves as a Senior Government Affairs Manager at The National Service Office for Nurse-Family Partnership and Child First. In this role, she oversees public policy and payer strategies to promote the evidence-based services of the NFP and Child First nursing and mental health home visiting models. Brittany holds a BS in Political Communications from The University of Texas at Austin and a MPH in Health Policy from The George Washington University.×